ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1808

Not Only Type-I Interferon Regulated Genes Are Differentially Expressed in Circulating Monocytes from Active Lupus Nephritis Patients

Paula Losada Vanegas1, Juan Antonio Villatoro-García2, Daniel Rodriguez3, Juan Camilo Diaz3, Ricardo Pineda4, Pedro Carmona-Saez5, Mauricio Rojas6 and Gloria Vasquez7, 1Universidad de Antioquia, Medellin, Antioquia, Colombia, 2GENYO (Centre for Genomics and Oncological Research: Pfizer, University of Granada, Granada, Andalucia, Spain, 3ARTMEDICA, Medellín, Antioquia, Colombia, 4ARTMEDICA, Medellin, Antioquia, Colombia, 5GENYO (Centre for Genomics and Oncological Research: Pfizer, University of Granada, Granada, Asturias, Spain, 6Grupo de Inmunología Celular e Inmunogenética, Sede de Investigación Universitaria. Facultad de Medicina. Universidad de Antioquia, Medellin, Antioquia, Colombia, 7Grupo de Inmunología Celular e Inmunogenética, Sede de Investigación Universitaria. Facultad de Medicina.Universidad de Antioquia, Medellin, Colombia

Meeting: ACR Convergence 2024

Keywords: Biomarkers, Gene Expression, Lupus nephritis, Monocytes/macrophages, Nephritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: SLE – Etiology & Pathogenesis Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Monocytes play an important role in organ damage, such as in Lupus Nephritis (LN). Although monocytes are typically considered inflammatory cells, evidence shows they also play crucial roles in antigen presentation, homing, wound healing, and fibrosis. The present study aims to identify transcriptomic signatures in circulating monocytes linked to the immune response in active Lupus Nephritis (aLN).

Methods: Circulating monocytes were sorted by FACS from three aLN female patients confirmed by kidney biopsy during initial treatment phase and three female non-SLE Donors (nSD), matched by similar age. After RNA extraction, the transcriptomes were assessed by Next Generation RNA sequencing with Illumina Novaseq platform. Analyses were addressed to identify Differentially Expressed Genes (DEGs). The statistically significant DEGs were compared with an IFN-Regulated gene Signature (IRS) described for interpheronopaties and the resulting set of DEGs were considered as out of the IRS. A list of DEGs from a previous report of SLE-monocyte transcriptional profile was used as a reference of genes highly expressed in our study. The IRS was excluded and the overlapping DEGs between the two studies were assessed. Functional categories and interaction network analysis focusing on immune genes and pathways were addressed to explore the bridging role of the DEGs in circulating monocyte transcriptional profile in the context of aLN.

Results: Monocyte gene expression profiling recognized 176 up-regulated genes differentially expressed in aLN vs nSD. Functional enrichment analysis showed that the most significant functional terms were related to inflammatory response, innate immune response, complement, and coagulation pathways. IRS was present with 23 up-regulated genes. We identified a set of 23 genes out of the IRS list that overlapped with the DEGs previously reported in sorted monocytes from SLE patients. OTOF was the most significant up-regulated gene out of the IRS list. It is a type-I IFN gene related to early anti-inflammatory response and repair and has been reported as a potential marker in SLE flare. Interestingly, the other most significant DEGs were SERPING1 and LGALS3BP and they are not type-I interferon-regulated genes. SERPING1 provides instructions to produce C1 inhibitor. Furthermore, the interaction network analysis for SERPING1 showed that it also has an association with SELP (Selectin P gene), which mediates the interaction between monocytes and neutrophils with activated endothelial cells.  Finally, LGALS3BP, a promising biomarker for lupus nephritis, encodes Galectin-3-binding protein was mainly associated with some proteins involved in cell adhesion such as FN1 (fibronectin), other galectin-binding proteins, and sialic acid-binding Ig-like lectin 10 (SIGLEC10).

Conclusion: Circulating monocytes exhibit a remarkable expression of genes associated with the IFN response in aLN patients. However, not only were type-I IFN-regulated genes in monocytes induced. We also identified different genes involved in pathogenic pathways such as complement activation, cell adhesion, and wound healing, which underlie renal involvement in SLE.


Disclosures: P. Losada Vanegas: None; J. Villatoro-García: None; D. Rodriguez: None; J. Diaz: None; R. Pineda: None; P. Carmona-Saez: None; M. Rojas: None; G. Vasquez: None.

To cite this abstract in AMA style:

Losada Vanegas P, Villatoro-García J, Rodriguez D, Diaz J, Pineda R, Carmona-Saez P, Rojas M, Vasquez G. Not Only Type-I Interferon Regulated Genes Are Differentially Expressed in Circulating Monocytes from Active Lupus Nephritis Patients [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/not-only-type-i-interferon-regulated-genes-are-differentially-expressed-in-circulating-monocytes-from-active-lupus-nephritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/not-only-type-i-interferon-regulated-genes-are-differentially-expressed-in-circulating-monocytes-from-active-lupus-nephritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology